Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
Associations between modifiable factors and the efficacy of cancer immunotherapies remain uncertain. We found previously that diet-induced obesity (DIO) reduces the efficacy of an immunotherapy consisting of adenovirus-encoded TRAIL plus CpG oligonucleotide (AdT/CpG) in mice with renal tumors. To el...
Main Authors: | William J. Turbitt, Shannon K. Boi, Justin T. Gibson, Rachael M. Orlandella, Lyse A. Norian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/10/2295 |
Similar Items
-
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer
by: Rachael M. Orlandella, et al.
Published: (2020-10-01) -
Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
by: Megan M Y Hong, et al.
Published: (2022-03-01) -
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
by: Navid Sobhani, et al.
Published: (2021-03-01) -
PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis
by: Joseph A. Pereira, et al.
Published: (2023-03-01) -
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
by: Friederike Hoffmann, et al.
Published: (2023-07-01)